Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | DEPTOR | Q8TB45 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | RORC | P51449 | 1/20 | 0.36 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25291595 | 1.00 | SMN1; SMN2 (0.42) | SMN1; SMN2RAB9AALDH1A1HPGDTDP1 | |
| SCHEMBL11119914 | 0.78 | BLM (0.43) | SMN1; SMN2RAB9AALDH1A1MAPTMEN1 | |
| SCHEMBL6180241 | 0.74 | NPSR1 (0.39) | SMN1; SMN2RAB9AALDH1A1TDP1L3MBTL1 | |
| SCHEMBL421668 | 0.74 | NPSR1 (0.39) | SMN1; SMN2RAB9AALDH1A1TDP1L3MBTL1 | |
| SCHEMBL1098842 | 0.72 | ALDH1A1 (0.46) | SMN1; SMN2ALDH1A1HPGDTDP1L3MBTL1 | |
| SCHEMBL3679031 | 0.71 | RIPK1 (0.42) | SMN1; SMN2RAB9AALDH1A1L3MBTL1MEN1 | |
| SCHEMBL3280418 | 0.71 | POLB (0.55) | SMN1; SMN2ALDH1A1HPGDTDP1DEPTOR | |
| SCHEMBL11262719 | 0.69 | POLB (0.53) | SMN1; SMN2ALDH1A1HPGDTDP1DEPTOR | |
| SCHEMBL7684 | 0.69 | CES1 (0.58) | SMN1; SMN2ALDH1A1HPGDTDP1L3MBTL1 | |
| SCHEMBL414466 | 0.69 | CES1 (0.58) | SMN1; SMN2ALDH1A1HPGDTDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9765294-B2 | Chemically defined medium for the industrial scale culture of a species of Bordetella | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2017-09-19 | — | — | US | claimed |
| EP-3044308-B1 | A CHEMICALLY DEFINED MEDIUM FOR THE INDUSTRIAL SCALE CULTURE OF A SPECIES OF BORDETELLA | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2017-08-09 | — | — | EP | claimed |
| US-20160222344-A1 | A CHEMICALLY DEFINED MEDIUM FOR THE INDUSTRIAL SCALE CULTURE OF A SPECIES OF BORDETELLA | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2016-08-04 | — | — | US | claimed |
| EP-3044308-A1 | A CHEMICALLY DEFINED MEDIUM FOR THE INDUSTRIAL SCALE CULTURE OF A SPECIES OF BORDETELLA | GlaxoSmithKline Biologicals S.A. (BE) | 2016-07-20 | — | — | EP | claimed |
| WO-2015036953-A1 | A CHEMICALLY DEFINED MEDIUM FOR THE INDUSTRIAL SCALE CULTURE OF A SPECIES OF BORDETELLA | GLAXOSMITHKLINE BIOLOGICALS, S.A. (BE) | 2015-03-19 | — | — | WO | claimed |
| EP-2330897-A1 | NGAL-BINDING SIDEROPHORES AND USE THEREOF TO TREAT IRON DEFICIENCY AND IRON OVERLOAD | The Trustees of Columbia University in the City of New York (US) | 2011-06-15 | — | — | EP | claimed |
| WO-2010033847-A1 | NGAL-BINDING SIDEROPHORES AND USE THEREOF TO TREAT IRON DEFICIENCY AND IRON OVERLOAD | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2010-03-25 | — | — | WO | claimed |
| US-12516089-B2 | Bacteria based protein delivery | T3 PHARMACEUTICALS AG (CH) | 2026-01-06 | — | — | US | disclosed |
| US-20250368691-A1 | Virulence Attenuated Bacteria Based Protein Delivery | UNIV BASEL (CH) | 2025-12-04 | — | — | US | disclosed |
| US-12358955-B2 | Virulence attenuated bacteria based protein delivery | UNIVERSITAET BASEL (CH) | 2025-07-15 | — | — | US | disclosed |
| US-20240165265-A1 | Pharmaceutical Combinations for Treating Cancer | T3 PHARMACEUTICALS AG (CH) | 2024-05-23 | — | — | US | disclosed |
| US-20240165169-A1 | Pharmaceutical Combinations for Treating Cancer | T3 PHARMACEUTICALS AG (CH) | 2024-05-23 | — | — | US | disclosed |
| CN-118006531-A | Attenuated bacteria-based protein delivery | 巴塞尔大学 | 2024-05-10 | — | — | CN | disclosed |
| EP-0983343-A1 | E. COLI, SALMONELLA OR HAFNIA AUTOINDUCERS | UNIVERSITY OF LEICESTER (GB) | 2000-03-08 | — | — | EP | disclosed |
| WO-1998053047-A1 | E. COLI, SALMONELLA OR HAFNIA AUTOINDUCERS | UNIVERSITY OF LEICESTER (GB) | 1998-11-26 | — | — | WO | disclosed |
| EP-0861321-A2 | PHOSPHOPANTETHEINYL TRANSFERASES AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1998-09-02 | — | — | EP | disclosed |
| WO-1997013845-A9 | PHOSPHOPANTETHEINYL TRANSFERASES AND USES THEREOF | — | 1997-08-14 | — | — | WO | disclosed |
| WO-1997013845-A2 | PHOSPHOPANTETHEINYL TRANSFERASES AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1997-04-17 | — | — | WO | disclosed |
| WO-1990011349-A1 | VACCINES FOR COMBATTING SEPTICEMIC BACTERIA | RHONE-MERIEUX S.A. (FR) | 1990-10-04 | — | — | WO | disclosed |
| EP-0389347-A1 | Vaccines against septicemic bacteria | RHONE MERIEUX (FR) | 1990-09-26 | — | — | EP | disclosed |